These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4555188)

  • 1. [Prolongation of the survival of primary and secondary allografts in rats using antilymphocyte serum].
    Kirzon SS; Khundanov LL; Verbitskiĭ MSh; Nastoiashchaia NN
    Biull Eksp Biol Med; 1972 Apr; 73(4):90-1. PubMed ID: 4555188
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolongation of the survival of skin allografts by the injection of spleen cells in adult mice treated by antilymphocyte serum.
    Brochier J; Fries D
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):303-7. PubMed ID: 4559763
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigenic and immunogenic capacities of cell membranes with and without antilymphocyte serum.
    Matolo NM; Reemtsma K; DeWitt CW
    Surg Forum; 1971; 22():282-4. PubMed ID: 4941315
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of long term survival of renal allografts after treatment with antilymphocyte antibody.
    Guttmann RD; Lindquist RR; Ockner SA; Merrill JP
    Transplant Proc; 1969 Mar; 1(1):463-6. PubMed ID: 4944260
    [No Abstract]   [Full Text] [Related]  

  • 5. [A comparative study of the effect of ALS against normal and sensitized lymphocytes on the viability of rat skin transplants].
    Antonenko LI
    Fiziol Zh; 1974; 20(5):590-6. PubMed ID: 4619073
    [No Abstract]   [Full Text] [Related]  

  • 6. Antilymphocyte serum and lymphatic system. I. The effect of regional administration on the survival of skin allografts.
    Málek P; Kolc J; Hasková V; Zástava V
    Transplantation; 1969 Oct; 8(4):333-7. PubMed ID: 4914422
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of murine cardiac allografts with antilymphocyte serum.
    Judd KP; Allen CR; Guiberteau MJ; Trentin JJ
    Transplant Proc; 1969 Mar; 1(1):470-3. PubMed ID: 4944262
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of skin homograft survival by mouse-anti-mouse thymocyte isoantiserum.
    Taub RN
    Transplant Proc; 1969 Mar; 1(1):445-7. PubMed ID: 4944258
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of antilymphocyte serum in the induction of immunological tolerance to tissue allografts.
    Monaco AP
    Fed Proc; 1970; 29(1):153-5. PubMed ID: 4904620
    [No Abstract]   [Full Text] [Related]  

  • 10. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of antilymphocyte serum in transplantation (literature review)].
    Govallo VI; Kosmiadi GA
    Khirurgiia (Mosk); 1971 Jan; 47(1):142-6. PubMed ID: 4930584
    [No Abstract]   [Full Text] [Related]  

  • 12. Antilymphocyte serum and procarbazine compared as immunosuppressants in mice, rats and rabbits.
    Stewart PB; Bell R
    Laval Med; 1970 Apr; 41(4):599-606. PubMed ID: 4929813
    [No Abstract]   [Full Text] [Related]  

  • 13. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unresponsiveness to skin allografts induced by tissue extracts and antilymphocytic serum.
    Brent L; Hansen JA; Kilshaw PJ
    Transplant Proc; 1971 Mar; 3(1):684-7. PubMed ID: 4937959
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolongation of survival of allogeneic skin grafts by L-asparaginase. Preliminary report.
    Hammer C; Brendel W
    Eur Surg Res; 1971; 3(1):72-5. PubMed ID: 4939504
    [No Abstract]   [Full Text] [Related]  

  • 16. Passive enhancement of renal allografts. Specificity of the enhancing antisera.
    Fabre JW; Batchelor JR
    Transplantation; 1975 Sep; 20(3):269-71. PubMed ID: 1099733
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antilymphocyte serum: methods for its preparation and measurement in vitro of its biological activity].
    Tursi A
    Haematologica; 1970 Dec; 55(12):766-73. PubMed ID: 5003116
    [No Abstract]   [Full Text] [Related]  

  • 18. Indirect evidence of two adverse components of the humoral response to skin allografts as revealed in ALS-suppressed mice.
    Nouza K; Hilgert I; Nĕmec M; Kristofová H
    Folia Biol (Praha); 1972; 18(4):264-9. PubMed ID: 4559929
    [No Abstract]   [Full Text] [Related]  

  • 19. Prolongation of allograft survival by specific antibody-to-lymphocyte-activating substances.
    Falk RE; Hancock DJ; Langer B
    Surgery; 1971 Jul; 70(1):123-7. PubMed ID: 4933440
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibiting collagen crosslinking on survival of skin allografts.
    Weiner LJ; Happel TJ; Madden JW
    Surg Forum; 1971; 22():486-7. PubMed ID: 4941329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.